Acasti Pharma Inc. ACST NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score

40/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

共有 50 笔近期内部人交易记录记录，涉及 Acasti Pharma Inc. (ACST), 包括 35 笔买入 和 7 笔卖出. 内部人买入总额为 $3.21M 内部人卖出总额为 $760.81K.

近期活跃的重要内部人包括 Adar1 Capital Management, Llc, Macdonald R. Loch, Delaversano Robert J. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — ACST

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2024-06-28	Adar1 Capital Management, Llc	10 Percent Owner	未知	-	-	-	959,571
2024-05-06	Macdonald R. Loch	Chief Medical Officer	限制性股票授予 (RSU)	25,380	$2.96	$75.12K	25,380
2024-05-06	Delaversano Robert J	Principal Financial Officer	限制性股票授予 (RSU)	4,500	$2.96	$13.32K	4,500
2024-05-06	Kohli Prashant	Chief Executive Officer	限制性股票授予 (RSU)	128,770	$2.96	$381.16K	128,770
2024-05-06	D'andrea Carrie	VP Program Management	限制性股票授予 (RSU)	19,740	$2.96	$58.43K	19,740
2024-05-06	Kumar Amresh	VP Clinical Operations	限制性股票授予 (RSU)	19,740	$2.96	$58.43K	19,740
2024-01-05	Delaversano Robert J	Vice President, Finance	处置	42,000	$2.13	$89.25K	-
2023-12-19	Davis A Brian	Director	限制性股票授予 (RSU)	22,500	$2.13	$47.81K	22,500
2023-12-19	Neugeboren Edward	Director	限制性股票授予 (RSU)	22,500	$2.13	$47.81K	22,500
2023-12-19	Kavuru Vimal	10 Percent Owner	限制性股票授予 (RSU)	10,000	$2.13	$21.25K	10,000
2023-12-19	Kottayil George	Director	限制性股票授予 (RSU)	22,500	$2.13	$47.81K	22,500
2023-12-19	Kohli Prashant	Chief Executive Officer	限制性股票授予 (RSU)	41,668	$2.13	$88.54K	41,668
2023-10-10	Davis A Brian	Director	未知	-	-	-	-
2023-10-10	Neugeboren Edward	Director	处置	-	-	-	37,895
2023-10-10	Kottayil George	Director	未知	-	-	-	124,344
2023-09-25	Kavuru Vimal	10 Percent Owner	知情买入	422,732	$3.00	$1.27M	422,732
2023-09-25	Adar1 Capital Management, Llc	10 Percent Owner	未知	913,631	$0.00	$91.36	-
2023-08-31	Olds Donald	Director	知情买入	381	$2.05	$781.05	381
2023-07-14	Macdonald R. Loch	Chief Medical Officer	限制性股票授予 (RSU)	60,000	$2.64	$158.4K	60,000
2023-07-14	Kavuru Vimal	Director	限制性股票授予 (RSU)	12,500	$2.64	$33K	12,500
2023-07-14	Olds Donald	Director	限制性股票授予 (RSU)	12,500	$2.64	$33K	12,500
2023-07-14	Derby Michael	Director	限制性股票授予 (RSU)	12,500	$2.64	$33K	12,500
2023-07-14	Kohli Prashant	Chief Executive Officer	限制性股票授予 (RSU)	208,334	$2.64	$550K	208,334
2023-07-14	D'andrea Carrie	VP Clinical Operations	限制性股票授予 (RSU)	42,000	$2.64	$110.88K	42,000
2023-07-14	Kumar Amresh	VP Program Management	限制性股票授予 (RSU)	42,000	$2.64	$110.88K	42,000
2023-05-08	D'andrea Carrie	Officer	未知	-	-	-	-
2023-05-08	Kumar Amresh	VP Program Management	处置	-	-	-	66,712
2023-05-08	Macdonald R. Loch	Officer	未知	-	-	-	-
2022-09-28	Canan John	Director	限制性股票授予 (RSU)	45,000	-	-	45,000
2022-09-28	Kavuru Vimal	Director	限制性股票授予 (RSU)	45,000	-	-	45,000
2022-09-28	Olds Donald	Director	限制性股票授予 (RSU)	45,000	-	-	45,000
2022-09-28	Derby Michael	Director	限制性股票授予 (RSU)	85,000	-	-	85,000
2022-09-09	Kohli Prashant	Cco	处置	124,100	$1.63	$202.28K	-
2022-06-22	Lemieux Pierre	COO, Canada & CSO	限制性股票授予 (RSU)	165,000	-	-	165,000
2022-06-22	D'alvise Janelle	President & CEO	限制性股票授予 (RSU)	560,000	-	-	560,000
2022-06-22	Ford Brian D.	Chief Financial Officer	限制性股票授予 (RSU)	165,000	-	-	165,000
2022-06-22	Kottayil George	COO, Us	限制性股票授予 (RSU)	50,000	-	-	50,000
2022-03-24	Derby Michael	Director	未知	-	-	-	-
2021-11-12	Haseltine William A	Director	限制性股票授予 (RSU)	42,100	-	-	42,100
2021-11-12	Canan John	Director	限制性股票授予 (RSU)	42,100	$1.63	$68.62K	42,100
2021-11-12	Kavuru Vimal	Director	限制性股票授予 (RSU)	42,100	-	-	42,100
2021-11-12	Lemieux Pierre	COO, Canada & CSO	限制性股票授予 (RSU)	287,900	-	-	287,900
2021-11-12	D'alvise Janelle	President & CEO	限制性股票授予 (RSU)	655,500	-	-	655,500
2021-11-12	Carter Roderick Noel	Director	限制性股票授予 (RSU)	42,100	-	-	42,100
2021-11-12	Olds Donald	Director	限制性股票授予 (RSU)	42,100	-	-	42,100
2021-11-12	Ford Brian D.	Chief Financial Officer	限制性股票授予 (RSU)	287,900	-	-	287,900
2021-11-10	Kottayil George	COO, Us	处置	287,900	$1.63	$469.28K	-
2021-08-27	Rajitha Grace 2018 Irrevocable Trust	Director	处置	-	-	-	4,689,547
2021-08-27	Kavuru Vimal	Director	未知	-	-	-	746,064
2021-08-27	Haseltine William A	Director	处置	-	-	-	7,105